Disulfide linkage controls the affinity and stoichiometry of IgE Fcε3-4 binding to FcεRI
Disulfide linkage controls the affinity and stoichiometry of IgE Fcε3-4 binding to FcεRI
复制标题
DOI:
10.1074/jbc.m500965200
复制
发表时间:
2005-04-29
影响因子:
4.8
通讯作者:
Beavil, AJ
中科院分区:
文献类型:
--
作者:
Hunt, J;Beavil, RL;Beavil, AJ
IgE antibodies cause long-term sensitization of tissue mast cells and blood basophils toward allergen-induced cross-linking and triggering of allergic inflammation. This persistence of IgE binding is due to its uniquely high affinity for the receptor Fc epsilon RI and in particular its slow rate of dissociation once bound. The binding interface consists of two subsites, one contributed by each C epsilon 3 domain of IgE Fc in a 1: 1 complex. We have investigated the contributions of C epsilon 3 disulfide linkage and glycosylation to the kinetics and affinity of binding of an Fc subfragment (Fc epsilon 3 - 4) to a soluble receptor fragment (sFc epsilon RI alpha). In contrast to IgG Fc where deglycosylation abrogates receptor binding activity, the removal of the N-linked carbohydrate at Asn-394 in Fc epsilon 3-4 only reduces binding affinity by a factor of 4, principally because of a faster off-rate. Removal of the inter-heavy chain disulfide bond unexpectedly resulted in a fragment with a much faster off-rate and the potential to form a complex with a 2: 1 stoichiometry (sFc epsilon RI alpha: Fc epsilon 3 4). This permitted the determination of the affinity of a single, natively folded C epsilon 3 domain for the first time. The low affinity K-a approximate to 10(5)-10(6) M-1, similar to that determined previously for an isolated and partially folded C epsilon 3 domain, demonstrates that substantial reduction in affinity can be achieved by preventing the engagement of one of the two C epsilon 3 domains. Recent structural data indicate that conformational change in IgE is required to allow both C epsilon 3 domains to bind, and thus an allosteric inhibitor that prevents access to the second C epsilon 3 has the potential to reduce the ability of IgE to sensitize allergic effector cells.